Free Trial

Quest PharmaTech (QPT) Insider Trading & Ownership

Quest PharmaTech logo
C$0.03 -0.01 (-14.29%)
(As of 05:22 PM ET)

Quest PharmaTech (CVE:QPT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.06%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
C$4,570.30
Number Of
Insiders Selling
(Last 3 Years)
0
Get QPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Quest PharmaTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

QPT Insider Buying and Selling by Quarter

Quest PharmaTech Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2023Ragupathy MadiyalakanDirectorBuy15,290C$0.07C$1,070.30
8/29/2023Ragupathy MadiyalakanDirectorBuy30,000C$0.07C$2,100.00
8/25/2023Ragupathy MadiyalakanDirectorBuy20,000C$0.07C$1,400.00
(Data available from 1/1/2013 forward)

QPT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Quest PharmaTech includes Ragupathy Madiyalakan. Learn more on insiders at QPT.

17.06% of Quest PharmaTech stock is owned by insiders. Learn more on QPT's insider holdings.

The following insider purchased QPT shares in the last 24 months: Ragupathy Madiyalakan (C$4,570.30).

Insiders have purchased a total of 65,290 QPT shares in the last 24 months for a total of C$4,570.30 bought.

Quest PharmaTech Key Executives

  • Dr. Ragupathy Madiyalakan Ph.D.
    CEO & Director
  • Mr. Pierre Vermette C.A.
    CPA, Chief Financial Officer
  • Mr. Roger Andrews
    Head of Investor Relations & Corporate Communications
  • Mr. Douglas C. Bachman (Age 70)
    Vice President of Corporate Development
    Compensation: $37.94k
  • Mr. Thomas Woo
    Vice President of Product Development


This page (CVE:QPT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners